SwePub
Sök i SwePub databas

  Extended search

Träfflista för sökning "WFRF:(Hermansson G) "

Search: WFRF:(Hermansson G)

  • Result 1-50 of 97
Sort/group result
   
EnumerationReferenceCoverFind
1.
  •  
2.
  • Aoyama, T., et al. (author)
  • The anomalous magnetic moment of the muon in the Standard Model
  • 2020
  • In: Physics reports. - : Elsevier BV. - 0370-1573 .- 1873-6270. ; 887, s. 1-166
  • Research review (peer-reviewed)abstract
    • We review the present status of the Standard Model calculation of the anomalous magnetic moment of the muon. This is performed in a perturbative expansion in the fine-structure constant α and is broken down into pure QED, electroweak, and hadronic contributions. The pure QED contribution is by far the largest and has been evaluated up to and including O(α5) with negligible numerical uncertainty. The electroweak contribution is suppressed by (mμ/MW)2 and only shows up at the level of the seventh significant digit. It has been evaluated up to two loops and is known to better than one percent. Hadronic contributions are the most difficult to calculate and are responsible for almost all of the theoretical uncertainty. The leading hadronic contribution appears at O(α2) and is due to hadronic vacuum polarization, whereas at O(α3) the hadronic light-by-light scattering contribution appears. Given the low characteristic scale of this observable, these contributions have to be calculated with nonperturbative methods, in particular, dispersion relations and the lattice approach to QCD. The largest part of this review is dedicated to a detailed account of recent efforts to improve the calculation of these two contributions with either a data-driven, dispersive approach, or a first-principle, lattice-QCD approach. The final result reads aμSM = 116 591 810(43) x 10-11 and is smaller than the Brookhaven measurement by 3.7 σ. The experimental uncertainty will soon be reduced by up to a factor four by the new experiment currently running at Fermilab, and also by the future J-PARC experiment. This and the prospects to further reduce the theoretical uncertainty in the near future - which are also discussed here - make this quantity one of the most promising places to look for evidence of new physics.
  •  
3.
  • Pfeifer, H., et al. (author)
  • Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph plus ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1
  • 2019
  • In: Leukemia. - : NATURE PUBLISHING GROUP. - 0887-6924 .- 1476-5551. ; 33:8, s. 1910-1922
  • Journal article (peer-reviewed)abstract
    • Minimal residual disease (MRD) is a powerful prognostic factor in acute lymphoblastic leukemia (ALL) and is used for patient stratification and treatment decisions, but its precise role in Philadelphia chromosome positive ALL is less clear. This uncertainty results largely from methodological differences relating to the use of real-time quantitative PCR (qRT-PCR) to measure BCR-ABL1 transcript levels for MRD analysis. We here describe the first results by the EURO-MRD consortium on standardization of qRT-PCR for the e1a2 BCR-ABL1 transcript in Ph + ALL, designed to overcome the lack of standardisation of laboratory procedures and data interpretation. Standardised use of EAC primer/probe sets and of centrally prepared plasmid standards had the greatest impact on reducing interlaboratory variability. In QC1 the proportion of analyses with BCR-ABL1/ABL1 ratios within half a log difference were 40/67 (60%) and 52/67 (78%) at 10(-3) and 36/67 (53%) and 53/67 (79%) at 10(-4)BCR-ABL1/ABL1. Standardized RNA extraction, cDNA synthesis and cycler platforms did not improve results further, whereas stringent application of technical criteria for assay quality and uniform criteria for data interpretation and reporting were essential. We provide detailed laboratory recommendations for the standardized MRD analysis in routine diagnostic settings and in multicenter clinical trials for Ph + ALL.
  •  
4.
  •  
5.
  • Gisterå, A., et al. (author)
  • Vaccination against T-cell epitopes of native ApoB100 reduces vascular inflammation and disease in a humanized mouse model of atherosclerosis
  • 2017
  • In: Journal of Internal Medicine. - : Wiley. - 0954-6820 .- 1365-2796. ; 281:4, s. 383-397
  • Journal article (peer-reviewed)abstract
    • Background and Objectives: The T-cell response to low-density lipoprotein (LDL) in the vessel wall plays a critical role in atherosclerotic plaque formation and stability. In this study, we used a new translational approach to investigate epitopes from human apolipoprotein B100 (ApoB100), the protein component of LDL, which triggers T-cell activation. We also evaluated the potential of two selected native ApoB100 epitopes to modulate atherosclerosis in human ApoB100-transgenic Ldlr-/- (HuBL) mice. Methods and Results: HuBL mice were immunized with human atherosclerotic plaque homogenate to boost cellular autoimmune response to tissue-derived ApoB100 epitopes. In vitro challenge of splenocytes from immunized mice with a library of overlapping native peptides covering human ApoB100 revealed several sequences eliciting T-cell proliferation. Of these sequences, peptide (P) 265 and P295 were predicted to bind several human leucocyte antigen (HLA) haplotypes and induced high levels of interferon (IFN)-γ. Vaccination of HuBL mice with these peptides mounted a strong adaptive immune response to native ApoB100, including high levels of epitope-specific plasma IgGs. Interestingly, P265 and P295 vaccines significantly decreased plaque size, reduced macrophage infiltration and increased IgG1 deposition in the plaques. Purified IgGs from vaccinated mice displayed anti-inflammatory properties against macrophages in vitro, reducing their response to LPS in a dose-dependent manner. Conclusion: We identified two specific epitopes from human native ApoB100 that trigger T-cell activation and protect HuBL mice against atherosclerosis when used in a vaccine. Our data suggest that vaccination-induced protective mechanisms may be mediated at least in part through specific antibody responses to LDL that inhibit macrophage activation.
  •  
6.
  •  
7.
  •  
8.
  • Isacsson, G., et al. (author)
  • Bibloc and Monobloc Oral appliances in the Treatment of Obstructive Sleep apnoea : a Multicenter, Randomized, Blinded, Parallel-Group Trial
  • 2017
  • In: Sleep Medicine. - : Elsevier. - 1389-9457 .- 1878-5506. ; 40:Suppl 1, s. E142-E143
  • Journal article (other academic/artistic)abstract
    • Introduction: The clinical benefit of bibloc over monobloc appliances has not been established in randomized trials treating obstructive sleep apnoea (OSA). We hypothesized that the two types of appliances are equally effective in treating moderate to severe OSA. Materials and methods: We performed a blinded, multicenter, randomized, controlled, prospective, parallel-group trial including patients aged 18 years or older who had moderate-to-severe OSA. Patients were randomly assigned to receive either a bibloc or a monobloc appliance with the intention to protrude the mandible 75% of the individual maximal protrusion capacity. At baseline a one-night respiratory polygraphy was done without any respiratory support. The polygraphy was iterated with the appliance in place at a 6-week follow-up. The primary outcome was the absolute change in the apnoea-hypopnea-index (AHI) from baseline to the 6-week follow-up, analysed in the per-protocol population. All patients who received an appliance were included in the safety analysis. This trial is registered with ClinicalTrials.gov, number NCT02148510, and approved by Uppsala Regional Ethical Review Board, Sweden (#2014/021). Results: We recruited patients from three dental specialist clinics in Sweden; enrolment of 302 patients was done between March 2014 and April 2016; 146 randomized to bibloc and 156 to monobloc appliance. Twenty-three patients in the bibloc group and 17 in the monobloc group were withdrawn due to reasons like appliance could not be fitted, lack of compliance, adverse events or non-valid follow-up polygraphy i.e. a per-protocol group of 123 bibloc and 139 monobloc treated patients. The mean change of AHI from baseline to 6 weeks of treatment was -13.8 (95% CI -16.1 to -11.5; p < 0.001) in the bibloc group and -12.5 (95% CI -14.8 to -10.3; p < 0.001) in the monobloc group. The mean difference was not significant between the groups (-1.3 (95% CI -4.5 to 1.9). The most common adverse event in the orofacial region was upper airway infection followed by complains from various parts of the mouth, jaws and teeth. Conclusions: Bibloc and monobloc appliance treatment was equal in their effects in treating OSA as measured by at home polygraphic respiratory measures and the appliances were associated with a similar degree of adverse events. Acknowledgements: Funding from Uppsala-Örebro Regional Research Council and Vastmanland County Council, Sweden.
  •  
9.
  •  
10.
  •  
11.
  •  
12.
  • Sacco, R. L., et al. (author)
  • Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke
  • 2008
  • In: New England Journal of Medicine. - Boston : Massachusetts medical society. - 1533-4406 .- 0028-4793. ; 359:12, s. 1238-51
  • Journal article (peer-reviewed)abstract
    • BACKGROUND: Recurrent stroke is a frequent, disabling event after ischemic stroke. This study compared the efficacy and safety of two antiplatelet regimens--aspirin plus extended-release dipyridamole (ASA-ERDP) versus clopidogrel. METHODS: In this double-blind, 2-by-2 factorial trial, we randomly assigned patients to receive 25 mg of aspirin plus 200 mg of extended-release dipyridamole twice daily or to receive 75 mg of clopidogrel daily. The primary outcome was first recurrence of stroke. The secondary outcome was a composite of stroke, myocardial infarction, or death from vascular causes. Sequential statistical testing of noninferiority (margin of 1.075), followed by superiority testing, was planned. RESULTS: A total of 20,332 patients were followed for a mean of 2.5 years. Recurrent stroke occurred in 916 patients (9.0%) receiving ASA-ERDP and in 898 patients (8.8%) receiving clopidogrel (hazard ratio, 1.01; 95% confidence interval [CI], 0.92 to 1.11). The secondary outcome occurred in 1333 patients (13.1%) in each group (hazard ratio for ASA-ERDP, 0.99; 95% CI, 0.92 to 1.07). There were more major hemorrhagic events among ASA-ERDP recipients (419 [4.1%]) than among clopidogrel recipients (365 [3.6%]) (hazard ratio, 1.15; 95% CI, 1.00 to 1.32), including intracranial hemorrhage (hazard ratio, 1.42; 95% CI, 1.11 to 1.83). The net risk of recurrent stroke or major hemorrhagic event was similar in the two groups (1194 ASA-ERDP recipients [11.7%], vs. 1156 clopidogrel recipients [11.4%]; hazard ratio, 1.03; 95% CI, 0.95 to 1.11). CONCLUSIONS: The trial did not meet the predefined criteria for noninferiority but showed similar rates of recurrent stroke with ASA-ERDP and with clopidogrel. There is no evidence that either of the two treatments was superior to the other in the prevention of recurrent stroke. (ClinicalTrials.gov number, NCT00153062.)
  •  
13.
  • Yusuf, S., et al. (author)
  • Telmisartan to prevent recurrent stroke and cardiovascular events
  • 2008
  • In: New England Journal of Medicine. - : Massachusetts medical society. - 1533-4406 .- 0028-4793. ; 359:12, s. 1225-37
  • Journal article (peer-reviewed)abstract
    • BACKGROUND: Prolonged lowering of blood pressure after a stroke reduces the risk of recurrent stroke. In addition, inhibition of the renin-angiotensin system in high-risk patients reduces the rate of subsequent cardiovascular events, including stroke. However, the effect of lowering of blood pressure with a renin-angiotensin system inhibitor soon after a stroke has not been clearly established. We evaluated the effects of therapy with an angiotensin-receptor blocker, telmisartan, initiated early after a stroke. METHODS: In a multicenter trial involving 20,332 patients who recently had an ischemic stroke, we randomly assigned 10,146 to receive telmisartan (80 mg daily) and 10,186 to receive placebo. The primary outcome was recurrent stroke. Secondary outcomes were major cardiovascular events (death from cardiovascular causes, recurrent stroke, myocardial infarction, or new or worsening heart failure) and new-onset diabetes. RESULTS: The median interval from stroke to randomization was 15 days. During a mean follow-up of 2.5 years, the mean blood pressure was 3.8/2.0 mm Hg lower in the telmisartan group than in the placebo group. A total of 880 patients (8.7%) in the telmisartan group and 934 patients (9.2%) in the placebo group had a subsequent stroke (hazard ratio in the telmisartan group, 0.95; 95% confidence interval [CI], 0.86 to 1.04; P=0.23). Major cardiovascular events occurred in 1367 patients (13.5%) in the telmisartan group and 1463 patients (14.4%) in the placebo group (hazard ratio, 0.94; 95% CI, 0.87 to 1.01; P=0.11). New-onset diabetes occurred in 1.7% of the telmisartan group and 2.1% of the placebo group (hazard ratio, 0.82; 95% CI, 0.65 to 1.04; P=0.10). CONCLUSIONS: Therapy with telmisartan initiated soon after an ischemic stroke and continued for 2.5 years did not significantly lower the rate of recurrent stroke, major cardiovascular events, or diabetes. (ClinicalTrials.gov number, NCT00153062.)
  •  
14.
  • Abrahamsson, Kate, 1959, et al. (author)
  • Bladder dysfunction: an integral part of the ectopic ureterocele complex.
  • 1998
  • In: The Journal of urology. - : Ovid Technologies (Wolters Kluwer Health). - 0022-5347 .- 1527-3792. ; 160:4, s. 1468-70
  • Journal article (peer-reviewed)abstract
    • We evaluate whether bladder dysfunction is common in patients with ectopic ureterocele and, if so, whether it is an integral part of the ectopic ureterocele complex or a result of surgery.From 1986 to 1995, 34 patients with a mean age of 10 months were treated for large or medium ectopic ureteroceles at our institution and 32 participated in postoperative followup. Bladder function was investigated by a careful history and repeat uroflowmetry, and residual urine estimation was assessed by ultrasound and cystometry.Of the 32 patients 19 had infrequent voiding and 3 had incontinence. Cystometric bladder capacity was increased to greater than 150% of the normal value for age in 15 of 27 patients (55%). Uroflowmetry revealed greater than 5 ml. residual urine in 15 patients (56%). Postoperatively no radiological signs of bladder neck obstruction were found. Increased bladder capacity and residual urine did not correlate with ureterocele size or location, or surgical procedure. There was no progression of bladder dysfunction with age.Children with ectopic ureterocele are at high risk for a high capacity bladder with incomplete emptying. This bladder dysfunction associated with ectopic ureterocele does not seem to be the result of surgery but an integral part of the disorder.
  •  
15.
  • ARUP, U, et al. (author)
  • Lavar
  • 2005
  • In: Gärdenfors, U (red.): Rödlistade arter i Sverige 2005, ArtDatabanken, SLU, Uppsala.
  • Research review (peer-reviewed)
  •  
16.
  •  
17.
  •  
18.
  • Bernin, Diana, 1979, et al. (author)
  • Microstructure of polymer hydrogels studied by pulsed field gradient NMR diffusion and TEM methods
  • 2011
  • In: Soft Matter. - : Royal Society of Chemistry (RSC). - 1744-683X .- 1744-6848. ; 7:12, s. 5711-5716
  • Journal article (peer-reviewed)abstract
    • The microstructure of various alginate gels have been studied by pulsed field gradient NMR (PFG NMR) and transmission electron microscopy (TEM). The reduced diffusivity of dendrimer diffusion within the gels has been obtained from PFG NMR diffusion experiments. The polymer strand radius, an important microstructural property, has been extracted from various diffusion models. The results agree well with the polymer strand radii obtained from image analysis of the corresponding TEM micrographs.
  •  
19.
  • Capsi-Morales, Patricia, et al. (author)
  • Functional assessment of current upper limb prostheses : An integrated clinical and technological perspective
  • 2023
  • In: PLOS ONE. - : Public Library of Science (PLoS). - 1932-6203. ; 18:8
  • Journal article (peer-reviewed)abstract
    • Although recent technological developments in the field of bionic upper limb prostheses, their rejection rate remains excessively high. The reasons are diverse (e.g. lack of functionality, control complexity, and comfortability) and most of these are reported only through self-rated questionnaires. Indeed, there is no quantitative evaluation of the extent to which a novel prosthetic solution can effectively address users' needs compared to other technologies. This manuscript discusses the challenges and limitations of current upper limb prosthetic devices and evaluates their functionality through a standard functional assessment, the Assessment of Capacity for Myoelectric Control (ACMC). To include a good representation of technologies, the authors collect information from participants in the Cybathlon Powered Arm Prostheses Race 2016 and 2020. The article analyzes 7 hour and 41 min of video footage to evaluate the performance of different prosthetic devices in various tasks inspired by activities of daily living (ADL). The results show that commercially-available rigid hands perform well in dexterous grasping, while body-powered solutions are more reliable and convenient for competitive environments. The article also highlights the importance of wrist design and control modality for successful execution of ADL. Moreover, we discuss the limitations of the evaluation methodology and suggest improvements for future assessments. With regard to future development, this work highlights the need for research in intuitive control of multiple degrees of freedom, adaptive solutions, and the integration of sensory feedback.
  •  
20.
  • Charlier, R, et al. (author)
  • Water Influence on Bearing Capacity and Pavement Performance : Field Observations
  • 2009
  • In: Water in Road Structures. - Dordrecht : Springer. - 9781402085611 ; , s. 175-192
  • Book chapter (peer-reviewed)abstract
    • This chapter presents a mechanical behaviour study, i.e. the bearing capacity as a function of the moisture degree. The field point of view is expressed and the chapter summarises a number of observations on road behaviour, in relation to variations of moisture. First, the road structure is recalled with respect to the mechanical analysis point of view. Then some observations on field under temperate climate, humid, are given. In a second step, the specific case of frost and thawing are discussed.
  •  
21.
  • Dahlvik, P, et al. (author)
  • Interactions in coating colours induced by a thermally active cellulosic polymer
  • 1999
  • In: Journal of Pulp and Paper Science (JPPS). - 0826-6220. ; 25, s. 229-234
  • Journal article (peer-reviewed)abstract
    • A thermally active polymer, ethyl hydroxyethyl cellulose (EHEC), was evaluated with respect to its ability to generate temperature-induced interactions between components in coating colors. At low temperatures the polymer is water soluble, providing a good flow behavior to the color. As the temperature is raised a phase separation of the polymer takes place, inducing an interaction between the components in the color. Rheological measurements showed that using EHEC as thickener resulted in a significant temperature-induced viscosity increase of the coating color. The increase in viscosity was found to be a result of interactions taking place between the three-component system consisting of EHEC, latex and pigment. The increase in viscosity with increasing temperature was further shown to correlate with the styrene/butadiene ratio in the latex. It was also found that a higher amount of EHEC was adsorbed on English clay than on ground calcium carbonate. This affected the degree of interaction within the three-component system EHEC-latex-pigment, in that the increase in viscosity with temperature was lower when English clay was used. However, when delaminated US clay was used, a strong temperature effect was detected.
  •  
22.
  • de Carolis, Stefano, et al. (author)
  • Structure and electronic properties of Ca-doped CeO2 and implications on catalytic activity : An experimental and theoretical study
  • 1999
  • In: J PHYS CHEM B. - : American Chemical Society (ACS). - 1089-5647. ; 103:36, s. 7627-7636
  • Journal article (peer-reviewed)abstract
    • Doping CeO2 with for example, Ca gives an enhanced reactivity toward reduction of SO2 by CO, and total combustion of methane. Theoretical modeling using static minimizations and molecular dynamics (MD) simulations of the doped (110) face in combination with ab initio quantum chemical cluster models shows large effects on the Ce(IV)/Ce(III) balance due to the doping. Computed oxygen-to-cerium charge-transfer energies are strongly reduced as a result of the introduction of defects and oxygen vacancies, but not sufficiently to explain the observed reactivities. The structures resulting from the MD simulations for both the doped and undoped material are in good agreement with recent experimental pulsed neutron scattering results.
  •  
23.
  •  
24.
  •  
25.
  •  
26.
  •  
27.
  •  
28.
  •  
29.
  •  
30.
  •  
31.
  •  
32.
  •  
33.
  • Eriksson, Bengt I., 1946, et al. (author)
  • Dose escalating safety study of a new oral direct thrombin inhibitor, dabigatran etexilate, in patients undergoing total hip replacement: BISTRO I
  • 2004
  • In: J Thromb Haemost. - 1538-7933. ; 2:9, s. 1573-80
  • Journal article (peer-reviewed)abstract
    • BACKGROUND: Dabigatran etexilate (BIBR 1048) is an oral direct thrombin inhibitor undergoing evaluation for the prevention of venous thromboembolism (VTE) following total hip replacement. Following oral administration, dabigatran etexilate is rapidly converted to its active form dabigatran (BIBR 953 ZW). OBJECTIVES: To determine the safe therapeutic range of dabigatran etexilate following total hip replacement. METHODS: In a multicenter, open-label, dose-escalating study, 314 patients received oral doses of dabigatran etexilate (12.5, 25, 50, 100, 150, 200 and 300 mg twice daily or 150 and 300 mg once daily) administered 4-8 h after surgery, for 6-10 days. Dose escalation was based on clinical and pharmacokinetic data. The primary safety outcome was major bleeding. The primary efficacy outcome included venographic deep vein thrombosis (DVT), symptomatic DVT and pulmonary embolism, during the treatment period. RESULTS: No major bleeding event was observed in any group, but two patients at the highest dose (300 mg twice daily) suffered bleeding from multiple sites associated with reduced renal clearance and prolonged pharmacodynamic (PD) parameters. A dose-response was demonstrated for minor bleeding events. Of the 289 treated patients, 225 patients had evaluable venograms. The overall incidence of DVT was 12.4% (28/225 patients). There was no consistent relationship between the dose and incidence of DVT, the highest incidence in any group being 20.8% (5/24 patients). The lowest dose (12.5 mg twice daily) showed a high rate of proximal DVT [12.5% (3/24)] and no increase in PD parameters. Peak and trough plasma concentrations, area under the dabigatran plasma concentration-time curve and PD parameters also increased in proportion with the dose. Higher dabigatran plasma concentrations were associated with lower DVT rates. Approximately 20% of the patients had low plasma concentrations after the first dose suggesting further optimization of the preliminary tablet formulation is required. CONCLUSIONS: Dabigatran etexilate demonstrates an acceptable safety profile, with a therapeutic window above 12.5 mg and below 300 mg twice daily. The low number of VTE events within each treatment group indicates a satisfactory antithrombotic potential, although the study was not powered for an efficacy analysis. Additional studies are ongoing to optimize oral absorption and the efficacy/safety balance.
  •  
34.
  •  
35.
  •  
36.
  • García-Gómez, Elisa, et al. (author)
  • Characterization of scrubber water discharges from ships using comprehensive suspect screening strategies based on GC-APCI-HRMS
  • 2023
  • In: Chemosphere. - 0045-6535 .- 1879-1298. ; 343
  • Journal article (peer-reviewed)abstract
    • An extended suspect screening approach for the comprehensive chemical characterization of scrubber discharge waters from exhaust gas cleaning systems (EGCSs), used to reduce atmospheric shipping emissions of sulphur oxides, was developed. The suspect screening was based on gas chromatography coupled with high-resolution mass spectrometry (GC-HRMS) and focused on the identification of polycyclic aromatic hydrocarbons (PAHs) and their alkylated derivatives (alkyl-PAHs), which are among the most frequent and potentially toxic organic contaminants detected in these matrices. Although alkyl-PAHs can be even more abundant than parent compounds, information regarding their occurrence in scrubber waters is scarce. For compound identification, an in-house compound database was built, with 26 suspect groups, including 25 parent PAHs and 23 alkyl-PAH homologues. With this approach, 7 PAHs and 12 clusters of alkyl-PAHs were tentatively identified, whose occurrence was finally confirmed by target analysis using GC coupled with tandem mass spectrometry (GC-MS/MS). Finally, a retrospective analysis was performed to identify other relevant (poly)cyclic aromatic compounds (PACs) of potential concern in scrubber waters. According to it, 18 suspect groups were tentatively identified, including biphenyls, dibenzofurans, dibenzothiophenes and oxygenated PAHs derivatives. All these compounds could be used as relevant markers of scrubber water contamination in heavy traffic marine areas and be considered as potential stressors when evaluating scrubber water toxicity.
  •  
37.
  • Ghirelli, Federico, 1971, et al. (author)
  • Reactor residence time analysis with CFD
  • 2006
  • In: Progress in computational fluid dynamics. ; 6:4/5, s. 241-247
  • Journal article (peer-reviewed)abstract
    • Abstract: The residence time of the fluid in a reactor can be analysed with at least three differentcomputational methods:(a) Eulerian simulation of the residence time measurements(b) solution of the Eulerian transport equation for residence time(c) Lagrangian particle tracking.Methods (a) and (c) are compared with analytical and experimental data from a pilot lagoon forvalidation, and the superiority of the Eulerian approach is demonstrated. Method (b), which hasbeen validated in earlier studies, is applied to study the flow in the secondary combustionchamber of a biomass grate furnace. An inefficiently exploited zone of the furnace is identified,and a change in operating conditions, aimed at improving the reactor utilisation, is discussed.
  •  
38.
  •  
39.
  •  
40.
  •  
41.
  •  
42.
  • Heinicke, G., et al. (author)
  • The effect of biological pre-filtration on the performance of conventional surface water treatment
  • 2006
  • In: Journal of Water Supply: Research and Technology - Aqua. - 0003-7214. ; 55:2, s. 109-119
  • Journal article (peer-reviewed)abstract
    • Many waterworks that apply conventional treatment of surface water, by flocculation and filtration, have to deal with seasonal changes of the raw water quality, increasing concentrations of natural organic matter (NOM), and the necessity to improve particle removal. A pilot plant was operated to closely resemble the full-scale treatment at a surface water treatment plant in Göteborg, Sweden. Treatment consisted of flocculation, sedimentation and rapid granular activated carbon (GAC) filtration. To assess the effects of biological pre-filtration, the feed water to the pilot plant was switched weekly between surface water and biofiltered water which had passed through adsorptively exhausted GAC at an empty bed contact time (EBCT) of 34 minutes. The processes were investigated with regard to NOM, the bacterial re-growth potential, as well as their function as a barrier for suspended particles that originate from the raw water. Biological pre-filtration improved particle removal and made it less dependent on the post-sedimentation GAC rapid filter, thereby improving robustness. Episodically elevated concentrations of earthy-musty odour compounds, which are not reliably removed by flocculation and filtration, were reduced by the biofilters. The process combination may be of particular interest for waterworks with variable raw water quality.
  •  
43.
  •  
44.
  •  
45.
  • Hermansson, A, et al. (author)
  • Inhibition of T cell response to native low-density lipoprotein reduces atherosclerosis
  • 2010
  • In: The Journal of experimental medicine. - : Rockefeller University Press. - 1540-9538 .- 0022-1007. ; 207:5, s. 1081-1093
  • Journal article (peer-reviewed)abstract
    • Immune responses to oxidized low-density lipoprotein (oxLDL) are proposed to be important in atherosclerosis. To identify the mechanisms of recognition that govern T cell responses to LDL particles, we generated T cell hybridomas from human ApoB100 transgenic (huB100tg) mice that were immunized with human oxLDL. Surprisingly, none of the hybridomas responded to oxidized LDL, only to native LDL and the purified LDL apolipoprotein ApoB100. However, sera from immunized mice contained IgG antibodies to oxLDL, suggesting that T cell responses to native ApoB100 help B cells making antibodies to oxLDL. ApoB100 responding CD4+ T cell hybridomas were MHC class II–restricted and expressed a single T cell receptor (TCR) variable (V) β chain, TRBV31, with different Vα chains. Immunization of huB100tgxLdlr−/− mice with a TRBV31-derived peptide induced anti-TRBV31 antibodies that blocked T cell recognition of ApoB100. This treatment significantly reduced atherosclerosis by 65%, with a concomitant reduction of macrophage infiltration and MHC class II expression in lesions. In conclusion, CD4+ T cells recognize epitopes on native ApoB100 protein, this response is associated with a limited set of clonotypic TCRs, and blocking TCR-dependent antigen recognition by these T cells protects against atherosclerosis.
  •  
46.
  •  
47.
  •  
48.
  • Hermansson, Cecilia, et al. (author)
  • DN Debatt: Klimatlagen kräver att regeringen ändrar politik
  • 2022
  • In: Dagens nyheter (DN debatt). - 1101-2447.
  • Journal article (pop. science, debate, etc.)abstract
    • Nästa år ska regeringen enligt klimatlagen presentera en handlingsplan för hur Sverige ska nå klimatmålen. Minst ett dussin myndigheter har bidragit med underlag. Men inte ens om samtliga förslag i dessa rapporter genomförs kommer det att räcka för att fylla det gap som har uppstått med den nya regeringens politik, skriver Klimatpolitiska rådet.
  •  
49.
  • Hermansson, Cecilia, et al. (author)
  • Klimatpolitiska rådets rapport 2023
  • 2023
  • Reports (pop. science, debate, etc.)abstract
    • Stigande halter av växthusgaser i atmosfären har rubbat balansen i jordens klimatsystem vilket har medfört en snabbt stigande global medeltemperatur. Den globala uppvärmningen ligger nu på drygt 1,1 grader jämfört med förindustriell tid. Utöver högre temperaturer har detta lett till fler extrema väderhändelser, smältande isar och stigande havsnivåer. De ekologiska, ekonomiska och sociala effekterna av klimatförändringarna blir allt påtagligare.
  •  
50.
  • Hermansson, J., et al. (author)
  • Complexes of the self-interstitial with oxygen in irradiated silicon : A new assignment of the 936 cm-1 band
  • 2001
  • In: Physica. B, Condensed matter. - 0921-4526 .- 1873-2135. ; 302-303, s. 188-192
  • Conference paper (other academic/artistic)abstract
    • Three vibrational infrared absorption bands at about 936, 944 and 956 cm-1 appear commonly in spectra of Czochralski-grown silicon irradiated at low temperatures. All three bands have earlier been assigned to local vibrational modes related to oxygen in the complex of the silicon and the oxygen interstitials (IOi). However, it is shown that such an assignment of the 936 cm-1 band clearly is inconsistent with many facts and observations and that the band is most likely due to oxygen vibrations in the Si interstitial pair and interstitial oxygen complex, I2Oi. © 2001 Published by Elsevier Science B.V.
  •  
Skapa referenser, mejla, bekava och länka
  • Result 1-50 of 97
Type of publication
journal article (65)
conference paper (24)
reports (4)
research review (2)
other publication (1)
book chapter (1)
show more...
show less...
Type of content
peer-reviewed (69)
other academic/artistic (25)
pop. science, debate, etc. (3)
Author/Editor
Hermansson, A (9)
Hermansson, Kersti (9)
Engqvist, Håkan (8)
Hermansson, G (7)
Thunman, Henrik, 197 ... (5)
Leckner, Bo G, 1936 (5)
show more...
Jacobsson, H (4)
Hansson, E (4)
Svensson, B. G. (3)
Hallberg, T (3)
Lindstrom, J L (3)
Bernin, Diana, 1979 (3)
Hansson, GK (3)
Hansson, G (3)
Hermansson, K (3)
Pais, P. (2)
Urban, J. (2)
Weber, M. (2)
Wurm, M. (2)
Harutyunyan, A. (2)
Kaste, M. (2)
Smartt, S. J. (2)
Persson, Frank, 1970 (2)
Smith, Henrik G. (2)
Yusuf, S. (2)
Roberts, R. (2)
Moore, Edward R.B. 1 ... (2)
Nydén, Magnus, 1970 (2)
von Euler, Mia, 1967 ... (2)
Söderholm, Patrik (2)
Toni, D. (2)
Benetti, S. (2)
Elias-Rosa, N. (2)
Jonsson, F (2)
Wibeck, Victoria (2)
Tegelberg, Åke (2)
Isacsson, G (2)
Malmström, Johan, 19 ... (2)
Thomsen, Peter, 1953 (2)
Gunnarsson, Lina-Mar ... (2)
Larsson, D. G. Joaki ... (2)
Förlin, Lars, 1950 (2)
Paulsson-Berne, G (2)
Bodin, L. (2)
Granérus, G (2)
Lu, C. (2)
Axén, Niklas (2)
Olsson, E (2)
Hellstrom, PM (2)
Bath, P (2)
show less...
University
Karolinska Institutet (25)
Uppsala University (24)
University of Gothenburg (17)
Chalmers University of Technology (14)
Lund University (8)
RISE (8)
show more...
Örebro University (6)
Linköping University (5)
Royal Institute of Technology (4)
University West (3)
Stockholm University (2)
Malmö University (2)
Umeå University (1)
Mid Sweden University (1)
Swedish University of Agricultural Sciences (1)
show less...
Language
English (88)
Swedish (9)
Research subject (UKÄ/SCB)
Natural sciences (23)
Medical and Health Sciences (22)
Engineering and Technology (8)
Agricultural Sciences (7)
Social Sciences (2)

Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view